Highlight

EQUIPMENT 2006, October 11   B Braun burnishes its image     French leader in the manufacture of medical materiel, B Braun Medical has five sites in France, including the certifiably “excellent” one located in Chasseneuil-du-Poitou, whose employees number 140. The information scarcely made a ripple, yet it merits a moment’s pause. Quite recently, B Braun Medical Chasseneuil was awarded the 2006 Janus health prize; the mark of distinction (the French “label”) was meant to honor the Celsite implantable chamber, which is manufactured close by, in Greater Poitiers. “In fact, this seal of approval rewards the design of a product that both facilitates practitioners’ work and provides patients with comfort”, stresses Brigitte Bardon, administrative and financial manager of the Chasseneuil site. Janus 2006 constitutes timely recognition of the efforts in R&D furnished by the leading French manufacturer of medical materiel. As a center of excellence, the Poitiers site researches, develops and manufactures its own products, which include vena cava filters (22,000 a year), implantable chambers (120,000) and stents. The implantable materiel of pronouncedly high added value winds up “landing” in French, other European and worldwide health centers. “B Braun exports throughout the world, particularly in the United States, Canada and Asia”, adds Brigitte Berton. New buildings Wishing to remain ahead of the game from a technological standpoint, earlier this year the Chasseneuil site equipped itself with a new work-related tool; the administrative offices and the production site (4000 m2 as opposed to 3000 m2) were all but metamorphosed. “The site dated from 1987. We had to improve the production tool”. In the process, B Braun invited the site’s economic and institutional actors to come and discover the new unit. "We likewise opened company doors to the employees’ families and friends”, indicates Brigitte Berton. Success guaranteed. If B Braun has agreed to major investments, the reason is that within the group, Chasseneuil represents an essential pole for R&D. As product prices steadily decrease, the French leader has been automating its production lines. “Even though we have new markets, we aren’t necessarily recruiting as a result.” On the other hand, hiring is more prevalent in the methods and R&D departments, that is to say at the very locus of the added value brought into being by B Braun. The Biopole en masse at Eurobio 2008 Read ...   Water information days (September 23 – September 25) Read ...   The rose and its genetic transformation Read ...   Christian Huyghe aims for “excellence” read...   Creating “medical branches” read...   A neuro-cardio-vascular pole is taking root read...   Valagro on the horticulture market read...   ERM, the winning spin-off read...   GMOs under debate in Poitiers read...   Isabelle Cameleyre, new representative read...   Cystic fibrosis: The molecule of hope read...   Irfaq, a manufacturer of innovations read...   CHU: State-of-the-art quality read...   Soil organic matter under examination read...   Parexel: The Cap provides its support read...   Philippe Michonneau: “The Biopole, fertile soil” read...   Painless monitoring of hepatitis read...   The Biopole structured as an association read...   Futuramat steps up the pace read...   Technova, or life in 3D read...   B Braun burnishes its image read...   Proteomics platform: The CHU strides ahead read...   The three missions of the University Botanical Garden read...   Clinsight in the big leagues read...   Natural energies for an autonomous building read...   Aster-Cephac turns into SGS Cephac read...   The previously unseen heart read...   BIOalternatives diversifies its markets read...   Two Poitiers-based projects awarded read...   IUT pores over biofuels read...   Poitiers, the biotechnology capital read...   PAREXEL wagers on the human factor read...   Saunier and associates wish to diversify read...   Biocydex and BioXtract move forward hand in hand read...   The grass of champions read...   Ianesco steadfastly believes in its future read...   A tumorotheque, what is the purpose it serves? read...   TechnAvOx has turned the corner read...   Larime is aiming for 40 beds in Poitiers read...   Poitiers is out to promote its research read...   A true Biopole milestone read...   A regional cancerology pole in the pipeline for 2007 read...   Nobel prize winners in Poitiers read...   A platform offering numerous advantages read...   @rtMolecule fashions in its own way read...   It’s plastic, it’s fantastic read...   The Poitiers hospital (CHU) stakes its claim read...   BIOalternatives exports its know-how read...   The physiological and computer science engineering program turns 30 read...   The Biopole takes center stage at Investiga read...           Legal mentions